AMENDMENT AND EXCHANGE AGREEMENTAmendment and Exchange Agreement • October 5th, 2018 • Innovate Biopharmaceuticals, Inc. • Pharmaceutical preparations
This Amendment and Exchange Agreement (the “Exchange Agreement”) is entered into as of the 4th day of October, 2018, by and among Innovate Biopharmaceuticals Inc., a Delaware corporation with offices located at 8480 Honeycutt Rd, Suite 120, Raleigh, NC 27615 (the “Company”), and the undersigned holder of the Existing Note (as defined below) (the “Holder”), with reference to the following facts:
